Acellular pertussis vaccine for adolescents.
出版信息
Paediatr Child Health. 2003 Jul;8(6):378-81. doi: 10.1093/pch/8.6.378.
Abstract
摘要
相似文献
1
Acellular pertussis vaccine for adolescents.青少年用无细胞百日咳疫苗。
Paediatr Child Health. 2003 Jul;8(6):378-81. doi: 10.1093/pch/8.6.378.
2
Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.低抗原含量破伤风-白喉-无细胞百日咳疫苗作为第六剂含无细胞百日咳疫苗在青少年中的安全性。
J Pediatr. 2006 Nov;149(5):603-610. doi: 10.1016/j.jpeds.2006.06.016.
3
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.吸附无细胞百白破灭活、全细胞百日咳和破伤风联合疫苗（Boostrix®）：作为单剂加强免疫的特性和用途介绍。
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
4
Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic.2012年华盛顿州百日咳疫情期间青少年的Tdap疫苗有效性
Pediatrics. 2015 Jun;135(6):981-9. doi: 10.1542/peds.2014-3358. Epub 2015 May 4.
5
Efficacy of an acellular pertussis vaccine among adolescents and adults.无细胞百日咳疫苗在青少年及成人中的效力
N Engl J Med. 2005 Oct 13;353(15):1555-63. doi: 10.1056/NEJMoa050824.
6
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.无细胞百白破疫苗在风险人群（青少年、孕妇、新生儿和医护人员）中的使用：证据回顾与建议。
Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15.
7
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.一种基因失活的两组分无细胞百日咳疫苗，单独或与破伤风和低剂量白喉疫苗联合使用，在青少年中的 2/3 期、随机对照非劣效性试验。
Lancet Infect Dis. 2018 Jan;18(1):58-67. doi: 10.1016/S1473-3099(17)30612-6. Epub 2017 Oct 20.
8
Acellular pertussis vaccines: new preparation. Better tolerated but less active?
Prescrire Int. 2000 Feb;9(45):204-7.
9
Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.用于青少年的无细胞百白破联合疫苗加强针
Pediatrics. 2006 Apr;117(4):1084-93. doi: 10.1542/peds.2005-1759.
10
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.一种由无细胞百日咳疫苗、白喉和破伤风类毒素以及灭活脊髓灰质炎病毒疫苗组成的成人剂型疫苗，在青少年和成人中是安全且具有免疫原性的。
Pediatr Infect Dis J. 2000 Apr;19(4):276-83. doi: 10.1097/00006454-200004000-00003.
引用本文的文献
1
A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents.西北地区百日咳发病率比较：儿童和青少年接种全细胞百白破疫苗前后。
Can J Infect Dis Med Microbiol. 2005 Sep;16(5):271-4. doi: 10.1155/2005/642315.
本文引用的文献
1
Pertussis immunization for adolescents: What are we waiting for?青少年百日咳免疫接种：我们还在等什么？
Paediatr Child Health. 2001 Apr;6(4):184-6. doi: 10.1093/pch/6.4.184.
2
Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and review.成人百日咳可能的严重并发症——颈动脉夹层：临床病例报告及文献复习
Clin Infect Dis. 2003 Jan 1;36(1):e1-4. doi: 10.1086/344776. Epub 2002 Dec 16.
3
The changing age and seasonal profile of pertussis in Canada.加拿大百日咳的年龄和季节性特征变化
J Infect Dis. 2002 May 15;185(10):1448-53. doi: 10.1086/340280. Epub 2002 Apr 22.
4
Morbidity of pertussis in adolescents and adults.青少年和成人百日咳的发病率。
J Infect Dis. 2000 Jul;182(1):174-9. doi: 10.1086/315648. Epub 2000 Jun 30.
5
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.一种与白喉和破伤风类毒素联合的五组分无细胞百日咳疫苗成人剂型在青少年和成人中是安全且具有免疫原性的。
Vaccine. 2000 Jan 31;18(14):1312-9. doi: 10.1016/s0264-410x(99)00415-6.
6
Notifiable diseases annual summary. 1992.法定传染病年度总结。1992年。
Can Commun Dis Rep. 1994 May;20 Suppl 1:1-93.
Zotero 插件